This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of skin of scalp and neck
CD2_INSITU_SKIN_SCALPNECK_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis verticis cranii
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin of scalp and neck
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin of scalp and neck
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 739 | 205 | 534 |
| Unadjusted period prevalence (%) | 0.19 | 0.07 | 0.24 |
| Median age at first event (years) | 78.01 | 77.79 | 78.10 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 629
- Matched controls
- 6291
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L57.0
ICD-10 Finland
Actinic keratosis
92.1
323.0
527
333
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
+∞
323.0
626
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
75.8
299.3
335
93
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
42.3
289.6
379
217
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
644.7
232.2
216
5
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
119.1
219.0
229
30
TQW99
NOMESCO Finland
Other minor procedure on skin
42.7
204.0
257
100
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
160.4
147
*
ZXC50
NOMESCO Finland
Cryotherapy
53.7
157.3
187
49
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
29.9
153.7
212
105
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
55.0
143.6
170
42
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
130.9
143.5
150
15
R23.8
ICD-10 Finland
Other and unspecified skin changes
12.3
142.8
299
430
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
53.2
141.9
169
43
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
139.9
129
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
133.1
123
*
D06BB10
ATC
imiquimod; topical
25.8
123.4
177
94
ZXC20
NOMESCO Finland
Use of chemical agents
59.6
103.7
121
25
ZXC15
NOMESCO Finland
Use of photodynamic technique
89.3
101.2
111
15
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
100.8
94
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
18.4
94.0
151
106
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
+∞
90.8
85
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
911.8
83.5
80
*
S18
ICPC
Laceration/cut
5.2
80.5
433
1876
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
295.9
78.4
78
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
221.9
77.1
78
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
74.5
70
*
ZZR00
NOMESCO Finland
Flap of skin
58.7
70.1
82
16
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
60.8
68.9
80
15
ZQZ00
NOMESCO Finland
Treatment of several skin areas
126.7
64.2
68
6
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
96.7
63.3
69
8
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
598.5
56.5
55
*
XQ848
NOMESCO Finland
Dermatological photography
22.2
55.7
82
42
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
25.2
53.8
76
34
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
30.1
52.1
70
26
116
Kela drug reimbursment
Prostate cancer
+∞
47.5
45
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
46.4
44
*
Z2221
NOMESCO Finland
Medical doctor
3.6
44.8
269
1074
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
56.4
44.3
52
10
SPAT1153
SPAT
Removal of sutures
3.4
42.8
303
1363
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
434.5
41.6
41
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
434.5
41.6
41
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.3
41.4
317
1496
L82
ICD-10 Finland
Seborrhoeic keratosis
4.2
40.4
179
542
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
16.9
39.2
63
41
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
38.9
37
*
130
Kela drug reimbursment
Malignant tumour
+∞
38.9
37
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
37.9
36
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
37.9
36
*
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
106.5
37.2
40
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
35.8
34
*
WX110
NOMESCO Finland
Local anesthesy
2.9
34.5
424
2617
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
59.2
33.6
39
7
ZXE00
NOMESCO Finland
One hour or less
2.8
33.2
312
1616
Z3231
NOMESCO Finland
Registered nurse
3.0
32.9
251
1132
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
22.0
32.2
47
23
R4110
NOMESCO Finland
Physiotherapy
3.0
32.0
237
1042
A98
ICPC
Health maint/preventive medicine
5.4
32.0
595
4800
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
31.7
213
877
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
11.1
31.6
61
60
ZXD10
NOMESCO Finland
Scheduled procedure
2.8
31.6
312
1645
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
41.4
31.5
39
10
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
31.5
30
*
S21
ICPC
Skin texture symptom/complaint
4.0
31.2
141
424
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
30.4
29
*
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
316.6
30.1
30
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
316.6
30.1
30
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
316.6
30.1
30
*
127
Kela drug reimbursment
Transplant complication
27.3
30.1
41
16
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
19.6
29.1
44
24
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
305.1
29.0
29
*
DAB00
NOMESCO Finland
Excision of lesion of auricle
31.0
28.8
38
13
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
14.3
28.2
48
36
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
67.2
28.2
32
5
E0000UV
ATC
NA
2.6
27.0
282
1496
JN4BD
NOMESCO Finland
Extensive body CT
5.4
25.9
82
170
D06BX02
ATC
ingenol mebutate; topical
13.0
25.9
46
38
S29
ICPC
Skin symptom/complaint other
3.2
25.6
159
604
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
25.2
24
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
25.2
24
*
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
+∞
25.2
24
*
WX002
NOMESCO Finland
Sedation and analgesia
2.9
25.1
187
801
J01DB01
ATC
cefalexin; oral
2.8
24.8
516
3894
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
24.4
359
2244
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.5
24.1
74
148
S77
ICPC
Malignant neoplasm of skin
70.2
24.0
27
*
L04AD01
ATC
ciclosporin; systemic
16.8
23.9
38
24
TQW80
NOMESCO Finland
Local dermatologic skincare
9.0
23.8
51
61
XQ845
NOMESCO Finland
Dermatoscopy
17.0
23.5
37
23
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
23.0
22
*
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
124.4
22.7
24
*
Z3226
NOMESCO Finland
Physiotherapist
2.9
22.5
164
689
Z51.5
ICD-10 Finland
Palliative care
7.2
22.4
55
82
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
22.0
21
*
DHB00
NOMESCO Finland
Excision of lesion of external nose
64.9
22.0
25
*
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
119.1
21.7
23
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.1
21.3
134
508
ZZA00
NOMESCO Finland
Split skin graft
7.2
21.1
52
78
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
+∞
20.9
20
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
+∞
20.9
20
*
DAB10
NOMESCO Finland
Partial excision of auricle
+∞
20.9
20
*
Z94.0
ICD-10 Finland
Kidney transplant status
20.9
20.5
30
15
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.2
20.2
65
137
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
9.1
19.9
42
49
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
30.0
19.8
26
9
A04AA02
ATC
granisetron; systemic, transdermal
108.4
19.7
21
*
ZZA50
NOMESCO Finland
Full thickness skin graft
206.0
19.7
20
*
H02AB02
ATC
dexamethasone; systemic
13.9
19.4
33
25
A04AA01
ATC
ondansetron; systemic, rectal
10.8
19.4
37
36
L04AA06
ATC
mycophenolic acid; systemic
13.3
19.1
33
26
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
18.8
18
*
N02BE01
ATC
paracetamol; systemic, rectal
2.7
18.8
546
4456
WF003
NOMESCO Finland
Adjuvant radiotherapy
195.4
18.6
19
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
31.1
18.4
24
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
18.3
172
825
L03AA13
ATC
pegfilgrastim; parenteral
+∞
17.8
17
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
17.8
17
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
17.8
17
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
184.8
17.6
18
*
B01AB10
ATC
tinzaparin; parenteral
4.8
17.6
60
135
XX3DW
NOMESCO Finland
Time consuming IT work
4.7
17.1
59
134
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.6
17.1
137
600
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
16.7
66
172
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.6
16.7
49
93
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
20.7
16.5
24
12
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
16.1
110
435
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.4
16.1
31
31
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
15.7
15
*
L02BB03
ATC
bicalutamide; oral
+∞
15.7
15
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
87.2
15.6
17
*
XW000
NOMESCO Finland
Bone marrow biopsy
5.5
15.5
46
89
WZC30
NOMESCO Finland
Teaching
3.1
15.1
86
301
TQW40
NOMESCO Finland
Remowal of suture of skin
4.2
14.9
57
144
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.3
14.8
163
836
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
25.7
14.8
20
8
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
14.6
14
*
L02BG04
ATC
letrozole; oral
+∞
14.6
14
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
14.6
14
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
14.6
14
*
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
82.0
14.6
16
*
L85.80
ICD-10 Finland
Hudhorn
82.0
14.6
16
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.2
14.6
45
91
JN4AD
NOMESCO Finland
Body CT examination
4.9
14.4
47
101
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
14.3
182
994
WX402
NOMESCO Finland
General anaesthesia
3.0
14.2
88
324
Z71.8
ICD-10 Finland
Other specified counselling
2.3
14.0
152
770
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
30.8
13.9
18
6
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
13.9
115
506
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
54.6
13.9
16
*
J01CA04
ATC
amoxicillin; systemic
2.0
13.7
460
3622
ZXA00
NOMESCO Finland
Right side
2.0
13.7
217
1294
UJF32
NOMESCO Finland
Coloscopy
2.1
13.7
193
1099
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
13.6
13
*
115
Kela drug reimbursment
Breast cancer
+∞
13.6
13
*
L04AA01
ATC
[U] ciclosporin; systemic
9.7
13.6
27
29
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.7
13.6
34
53
Y77
ICPC
Malignant neoplasm prostate
142.8
13.5
14
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
142.8
13.5
14
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.1
13.4
42
87
B07.9
ICD-10 Finland
Verruca simplex
6.1
13.3
36
62
ZX120
NOMESCO Finland
Intravenous
3.1
13.0
73
252
NK6AN
NOMESCO Finland
Total body bone isotope imaging
51.1
12.9
15
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
12.7
213
1292
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
12.6
156
833
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.8
12.6
35
63
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
12.5
12
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
12.5
12
*
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
+∞
12.5
12
*
C44.49
ICD-10 Finland
Malignant tumor of the skin of the scalp and of the neck other or unspecified histology
+∞
12.5
12
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
12.5
12
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.7
12.5
42
94
D07AB08
ATC
desonide; topical
2.8
12.2
85
337
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
12.2
276
1860
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.2
12.1
32
54
WW500
NOMESCO Finland
Blood transfusion
5.7
11.8
33
60
C90.0
ICD-10 Finland
Multiple myeloma
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
11.5
11
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
11.5
11
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
11.5
11
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
11.5
11
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
11.5
11
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
11.5
199
1212
WF004
NOMESCO Finland
Palliative radiotherapy
122.0
11.5
12
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
122.0
11.5
12
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
122.0
11.5
12
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
122.0
11.5
12
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.1
11.4
148
804
XKD00
NOMESCO Finland
Uroflowmetry
2.0
11.2
159
894
A03FA01
ATC
metoclopramide; systemic, rectal
2.7
11.2
79
317
L03AA02
ATC
filgrastim; parenteral
44.1
10.9
13
*
S82
ICPC
Naevus/mole
2.6
10.6
83
353
D07AB02
ATC
hydrocortisone butyrate; topical
1.9
10.6
176
1050
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
5.6
10.5
30
56
C44
ICD-10 Finland
Other malignant neoplasms of skin
111.7
10.4
11
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
10.4
10
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
10.4
10
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
10.4
10
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
10.4
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.4
10
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
10.4
10
*
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
10.4
10
*
TQW40
SPAT
NA
4.7
10.3
34
75
A11CC03
ATC
alfacalcidol; systemic
4.6
10.3
35
80
ZXD05
NOMESCO Finland
Urgent procedure
1.8
10.3
217
1405
ZXC10
NOMESCO Finland
Use of laser
6.4
10.2
26
42
137
Kela drug reimbursment
Uraemia requiring dialysis
13.4
10.2
17
13
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
13.4
10.2
17
13
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
4.5
10.2
35
81
A12AA04
ATC
calcium carbonate; oral
5.5
10.1
29
55
B01AB05
ATC
enoxaparin; parenteral
1.9
10.1
197
1241
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
40.7
10.0
12
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
17.0
9.9
15
9
N02AX02
ATC
tramadol; systemic, rectal
1.8
9.9
261
1811
C08CA01
ATC
amlodipine; oral
1.7
9.8
299
2165
D07XC01
ATC
betamethasone, combinations; topical
2.3
9.8
95
452
D07AC01
ATC
betamethasone; topical
1.8
9.6
224
1492
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
11.6
9.6
17
15
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
7.3
9.6
22
31
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
10.2
9.6
18
18
S15
ICPC
Foreign body in skin
3.0
9.5
54
188
M79.6
ICD-10 Finland
Pain in limb
1.8
9.5
223
1487
A79
ICPC
Malignancy NOS
101.4
9.4
10
*
XJH00
NOMESCO Finland
Transanal ultrasonography
2.6
9.4
70
290
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
9.4
9
*
L02BX02
ATC
degarelix; parenteral
+∞
9.4
9
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
9.4
9
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
9.4
9
*
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
+∞
9.4
9
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
ZY010
NOMESCO Finland
Hospital outpatient
4.9
9.3
29
61
ZXA05
NOMESCO Finland
Left side
1.8
9.2
189
1202
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
9.0
57
215
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
9.0
122
672
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
24.4
8.9
12
5
QAE99
SPAT
NA
12.8
8.9
15
12
D06BX01
ATC
metronidazole; topical
2.6
8.9
64
261
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
5.0
8.8
27
56
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.0
8.8
34
89
HAB40
NOMESCO Finland
Wedge excision of mammary gland
50.7
8.7
10
*
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
50.7
8.7
10
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
8.7
164
1015
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.8
8.6
35
96
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.7
8.6
59
235
C44.20
ICD-10 Finland
Malignant tumor of the skin of the outer ear and of the outer ear canal without histology
91.2
8.4
9
*
UJF30
NOMESCO Finland
Ileoscopy through colon
2.5
8.4
64
270
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
8.3
69
303
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
+∞
8.3
8
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
8.3
8
*
D04
ICD-10 Finland
Carcinoma in situ of skin
+∞
8.3
8
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
8.3
8
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
8.3
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.3
8
*
L01BC06
ATC
capecitabine; oral
+∞
8.3
8
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
8.3
8
*
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
+∞
8.3
8
*
ZXA10
NOMESCO Finland
Bilateral
1.9
8.3
147
887
Z2446
NOMESCO Finland
Social worker
3.1
8.3
45
154
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.5
8.2
37
110
205
Kela drug reimbursment
Chronic hypertension
1.7
8.2
266
1927
TK800
NOMESCO Finland
Hemodialysis
4.5
8.2
28
65
Z49.0
ICD-10 Finland
Preparatory care for dialysis
7.7
8.2
18
24
J05AB11
ATC
valaciclovir; oral
2.3
8.2
75
345
WX320
NOMESCO Finland
Spinalanesthesy
1.8
8.0
158
990
Z02.4
ICD-10 Finland
Examination for driving licence
1.7
7.9
220
1522
S99
ICPC
Skin disease other
5.5
7.9
22
41
L04AX01
ATC
azathioprine; systemic
3.3
7.9
38
120
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.0
7.8
30
78
A02BC02
ATC
pantoprazole; systemic
1.6
7.8
383
3084
J01MA12
ATC
levofloxacin; systemic
1.9
7.8
128
751
R4190
NOMESCO Finland
Nutritional therapy
6.5
7.8
19
30
L57.9
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation, unspecified
45.5
7.7
9
*
QXA05
NOMESCO Finland
Skin division, unspecified location
45.5
7.7
9
*
QAB05
NOMESCO Finland
Revision of wound of skin of head or neck
45.5
7.7
9
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
45.5
7.7
9
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
7.7
73
344
C09CA01
ATC
losartan; oral
1.7
7.6
177
1161
B03XA01
ATC
erythropoietin; parenteral
8.2
7.6
16
20
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.3
7.6
74
351
Z49.2
ICD-10 Finland
Other dialysis
12.0
7.6
13
11
PJA10
NOMESCO Finland
Exploration of lymph nodes
25.3
7.6
10
*
A60
ICPC
General and Unspecified, Result test/procedure
3.4
7.6
35
107
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.6
7.5
32
92
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
7.5
260
1906
D02AE01
ATC
carbamide; topical
2.8
7.5
47
176
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
7.4
39
131
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
7.4
119
691
Z49.1
ICD-10 Finland
Extracorporeal dialysis
5.4
7.4
21
40
TDA10
NOMESCO Finland
Needle biopsy of auricle or external auditory canal
80.9
7.4
8
*
L57
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation
13.5
7.4
12
9
J01AA04
ATC
lymecycline; systemic
2.4
7.4
61
269
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.6
7.4
31
88
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.0
7.4
42
148
M79.1
ICD-10 Finland
Myalgia
2.2
7.3
74
356
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
+∞
7.3
7
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
7.3
7
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
7.3
7
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
7.3
7
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.0
7.3
41
142
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
7.2
72
347
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
7.2
67
314
QAE15
NOMESCO Finland
Excision of other superficial lesion of skin from head and neck
30.4
7.2
9
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
30.4
7.2
9
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
7.1
133
814
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
20.3
7.1
10
5
B05DA
ATC
Isotonic solutions
12.2
7.1
12
10
ZXD20
NOMESCO Finland
Day surgery
2.1
7.1
84
437
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.6
7.0
49
197
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.6
7.0
251
1849
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.4
7.0
55
237
EBA10
NOMESCO Finland
Surgical removal of tooth
2.7
7.0
46
180
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.7
6.9
158
1031
S79
ICPC
Neoplasm skin benign/unspecified
4.9
6.9
21
44
R60.0
ICD-10 Finland
Localized oedema
2.0
6.9
92
501
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
11.1
6.8
12
11
J01FA10
ATC
azithromycin; systemic
1.6
6.8
246
1811
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
40.5
6.8
8
*
QAA10
NOMESCO Finland
Incision of skin of head or neck
40.5
6.8
8
*
Z94.4
ICD-10 Finland
Liver transplant status
40.5
6.8
8
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
40.5
6.8
8
*
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
16.9
6.8
10
6
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
16.9
6.8
10
6
3AC01
NOMESCO Finland
NA
7.3
6.7
15
21
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
6.7
103
588
E000001
ATC
NA
1.8
6.7
118
707
A02BC01
ATC
omeprazole; systemic
1.6
6.7
190
1312
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
7.9
6.6
14
18
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
7.9
6.6
14
18
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
12.4
6.6
11
9
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
6.6
326
2581
CBB30
NOMESCO Finland
Excision of lesion of eyelid
3.8
6.5
26
71
SPAT1325
SPAT
Vaccination
1.6
6.5
263
1984
J05AB01
ATC
aciclovir; systemic
1.8
6.4
108
638
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
70.5
6.4
7
*
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
70.5
6.4
7
*
1XC02
NOMESCO Finland
NA
14.5
6.4
10
7
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
6.4
114
686
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
6.4
186
1292
A44
ICPC
General and Unspecified, Preventive immunization/medic
2.4
6.4
54
241
M04AA01
ATC
allopurinol; systemic
1.8
6.3
126
784
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
6.0
6.3
16
27
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
18.2
6.3
9
5
U14
ICPC
Kidney symptom/complaint
4.9
6.3
19
40
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
6.3
436
3719
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
X76
ICPC
Malignant neoplasm breast female
+∞
6.3
6
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
6.3
6
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
6.3
6
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
6.3
6
*
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
+∞
6.3
6
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
6.3
6
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
6.3
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
+∞
6.3
6
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
6.3
6
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
6.3
6
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
6.3
6
*
153
Kela drug reimbursment
Lenalidomid
+∞
6.3
6
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.6
6.2
20
45
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.4
6.2
17
32
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.9
6.1
23
60
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.1
6.1
31
103
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
6.1
88
493
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
6.1
49
212
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
12.7
6.1
10
8
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
12.7
6.1
10
8
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
6.1
201
1440
C02EA02
ATC
NA
2.2
6.0
57
269
212
Kela drug reimbursment
Gout
3.4
6.0
27
82
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
359
368
18.03
307.65
2.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
612
1490
19.08
299.65
5.0
1.7
—
—
—
0
0
(4035726)
159
143
13.89
156.70
1.5
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
133
212
7.43
82.74
1.5
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
356
1784
2.92
44.42
9.0
4.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
490
2915
3.02
44.25
13.3
5.2
e9/l
4.5
4.7
0.80
431
2484
(3024561) Albumin [Mass/volume] in Serum or Plasma
452
2638
2.84
41.15
7.1
3.7
g/l
33.7
34.5
1.93
422
2406
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
189
689
3.34
40.86
5.5
2.6
u/l
238.8
243.3
0.25
182
636
(3018095) Leukocytes [#/volume] in Urine
393
2144
2.78
40.67
6.1
3.7
e6/l
92.4
118.0
0.41
288
1567
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
672
4939
4.98
40.62
28.8
15.6
ml/min/173m2
64.1
68.8
6.71
583
3970
(3021589) Normoblasts [#/volume] in Blood
414
2321
2.78
40.58
16.3
8.7
e9/l
0.0
0.0
0.39
348
1865
(3022096) Basophils/100 leukocytes in Blood
420
2376
2.78
40.38
9.9
4.8
%
0.6
0.6
1.12
389
2168
(3019069) Monocytes/100 leukocytes in Blood
429
2454
2.78
40.34
10.0
5.0
%
9.2
9.1
0.36
396
2242
(3023368) Bacteria identified in Blood by Culture
369
1958
2.77
40.20
5.2
4.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
426
2441
2.76
39.71
9.8
4.8
%
2.6
3.0
2.40
395
2223
(3001604) Monocytes [#/volume] in Blood
445
2613
2.77
39.41
8.9
4.5
e9/l
0.7
0.6
0.36
371
2196
(3002030) Lymphocytes/100 leukocytes in Blood
430
2484
2.75
39.30
10.0
5.0
%
25.6
24.6
0.65
397
2253
(3018418) pH of Serum or Plasma
347
1801
2.75
39.24
6.4
3.1
ph
7.4
7.4
0.41
70
300
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
469
2832
2.80
39.23
7.9
3.7
umol/l
14.4
12.9
1.42
448
2639
(3006315) Basophils [#/volume] in Blood
446
2626
2.76
39.21
8.9
4.5
e9/l
0.0
0.0
1.29
371
2217
(3015377) Calcium [Moles/volume] in Serum or Plasma
366
1952
2.73
39.21
4.4
2.1
mmol/l
2.3
2.3
0.01
301
1585
(3002582) Erythrocytes [#/volume] in Urine
357
1893
2.71
38.50
5.5
3.2
e6/l
77.5
113.7
0.37
280
1466
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
702
5400
6.99
38.42
28.4
16.4
mg/l
29.8
28.3
0.48
605
4376
(3002385) Erythrocyte distribution width [Ratio]
604
4213
3.37
37.92
35.5
19.6
%
14.3
13.9
5.90
593
4086
(3019198) Lymphocytes [#/volume] in Blood
446
2660
2.71
37.65
9.0
4.6
e9/l
2.8
1.7
1.29
376
2282
(3013115) Eosinophils [#/volume] in Blood
451
2707
2.71
37.54
9.7
4.6
e9/l
0.2
0.2
3.33
379
2313
(3018010) Neutrophils/100 leukocytes in Blood
423
2463
2.68
37.41
9.1
4.9
%
60.1
59.8
0.19
392
2254
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
52
69
8.03
37.37
6.8
4.1
iu/ml
454.4
188.0
—
10
6
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
605
4246
3.34
37.12
11.4
5.2
u/l
83.6
79.3
1.07
566
3878
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
717
5660
9.96
36.97
16.1
9.5
u/l
23.2
23.9
0.57
685
5351
(3030467) Casts [#/volume] in Urine by Automated count
331
1728
2.66
36.31
5.3
3.1
e6/l
0.4
0.5
0.60
255
1316
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
489
3090
2.72
36.11
10.7
5.5
mmol/l
1.2
1.2
0.08
419
2596
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
395
2254
2.62
35.95
5.3
3.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
165
595
3.28
35.92
10.9
5.2
mmol/l
12.7
12.2
0.29
157
557
(3019550) Sodium [Moles/volume] in Serum or Plasma
722
5776
11.87
35.67
33.4
20.7
mmol/l
139.4
139.7
1.55
708
5597
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
458
2814
2.65
35.63
8.7
5.2
mmol/l
1.2
1.2
0.34
425
2479
(3023103) Potassium [Moles/volume] in Serum or Plasma
722
5785
11.78
35.38
34.2
20.8
mmol/l
4.0
4.0
1.06
707
5607
(3004789) Transferrin [Mass/volume] in Serum or Plasma
223
966
2.87
35.08
4.0
2.4
g/l
2.2
2.2
0.25
205
879
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
216
921
2.90
34.98
4.1
2.5
%
21.0
21.8
0.35
194
764
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
116
338
3.88
34.97
3.8
1.3
ug/l
9.2
3.9
1.14
86
253
(3007461) Platelets [#/volume] in Blood
724
5837
12.84
34.71
41.1
23.8
e9/l
219.6
230.5
3.89
700
5616
(3024731) MCV [Entitic volume]
724
5837
12.84
34.71
41.0
23.7
fl
93.0
92.1
5.02
714
5688
(3000963) Hemoglobin [Mass/volume] in Blood
724
5838
12.83
34.67
41.4
23.9
g/l
129.4
133.5
8.35
714
5689
(3035941) MCH [Entitic mass]
724
5838
12.83
34.67
40.9
23.6
pg
30.7
30.6
0.84
714
5689
(3026361) Erythrocytes [#/volume] in Blood
724
5838
12.83
34.67
41.2
23.7
e12/l
4.3
4.4
6.90
699
5589
(3010813) Leukocytes [#/volume] in Blood
724
5839
12.82
34.64
41.2
23.8
e9/l
7.5
7.0
1.46
699
5592
(3044640) Blood type and Crossmatch panel - Blood
316
1658
2.58
33.73
3.6
2.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
561
3888
2.84
32.95
6.4
4.9
e6/l
309.2
3388.1
—
9
71
(3044889) 12 lead EKG panel
576
4059
2.90
32.51
5.6
4.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
309
1647
2.51
31.38
5.2
3.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
231
1072
2.68
31.32
4.0
2.4
umol/l
11.2
12.0
1.09
215
966
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
221
1010
2.70
30.83
4.4
3.0
e6/l
1.0
2.2
2.22
124
560
(3001122) Ferritin [Mass/volume] in Serum or Plasma
379
2235
2.43
30.57
4.1
2.8
ug/l
167.5
152.7
0.62
343
2018
(40758558) Short blood count panel - Blood
252
1233
2.58
30.55
10.5
4.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
442
2801
2.44
30.17
14.2
12.6
inr
1.4
1.5
0.34
130
761
(3003458) Phosphate [Moles/volume] in Serum or Plasma
195
848
2.77
29.88
10.9
4.5
mmol/l
1.0
1.0
0.50
185
772
(3045142) Bone marrow Pathology biopsy report
38
45
8.85
29.86
1.4
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
198
881
2.70
28.90
4.1
2.2
mmol/l
0.8
0.8
1.52
183
811
(3013826) Glucose [Moles/volume] in Serum or Plasma
522
3610
2.52
28.67
6.1
4.5
mmol/l
6.9
7.1
0.65
500
3389
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
89
247
3.96
28.55
2.1
1.4
g/l
0.9
0.5
0.50
76
208
(3020630) Protein [Mass/volume] in Serum or Plasma
150
580
2.99
28.48
2.4
1.6
g/l
64.2
66.3
2.55
135
514
(3037467) Urinalysis macro (dipstick) panel - Urine
558
3994
2.62
28.23
6.6
4.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
685
5490
4.39
27.99
24.4
16.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
81
214
4.13
27.78
1.8
1.4
g/l
0.0
0.0
0.02
73
197
(3000850) Epithelial cells [#/volume] in Urine
257
1327
2.44
27.22
4.2
2.4
e6/l
2.7
4.5
4.10
227
1153
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
143
553
2.97
27.06
3.8
2.2
umol/l
10.4
9.8
0.12
129
479
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
314
1782
2.33
26.67
2.9
2.3
mg/l
3.2
3.0
0.38
274
1500
(3042936) Bacteria identified in Isolate by Culture
192
873
2.62
26.59
2.1
2.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
288
1598
2.31
25.56
5.0
2.6
umol/l
13838.4
11348.2
0.20
248
1327
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
90
273
3.62
25.31
1.8
1.4
g/l
3.1
3.2
0.35
71
212
(3009542) Hematocrit [Volume Fraction] of Blood
597
4516
2.68
25.14
32.3
18.5
%
38.8
37.9
1.48
398
2562
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
188
867
2.57
25.13
1.9
1.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
218
1081
2.44
24.91
4.2
2.8
e6/l
2.3
1.3
0.41
120
627
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
244
1274
2.37
24.81
3.4
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
670
5400
3.58
24.79
6.2
5.6
mmol/l
2.3
2.4
3.11
591
4845
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
299
3.46
24.57
1.8
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
299
3.46
24.57
1.8
1.4
g/l
7.2
7.6
1.64
74
214
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
435
2901
2.21
24.12
2.4
2.2
pmol/l
90.0
91.2
0.21
240
1545
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
93
299
3.41
23.88
1.8
1.4
g/l
3.8
3.9
0.18
70
209
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
119
446
2.99
23.64
2.7
2.1
u/l
31.4
33.5
0.33
106
351
(3026782) Osmolality of Urine
240
1267
2.32
23.60
4.5
2.6
mosm/kgh2o
542.3
559.2
0.66
213
1059
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
237
1247
2.33
23.46
3.3
2.3
mmol/l
2.5
2.4
2.26
204
1056
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
233
1228
2.31
22.89
2.2
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
380
2436
2.15
22.88
5.3
3.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
358
2243
2.16
22.87
2.6
2.2
nmol/l
85.4
77.8
4.46
314
1897
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
79
235
3.64
22.82
1.8
1.4
g/l
37.3
36.4
0.64
66
195
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
297
1731
2.20
22.81
3.3
2.8
ug/l
0.9
0.8
0.23
210
1262
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
628
4958
2.78
22.64
5.0
4.4
mu/l
2.1
2.1
0.44
555
4379
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
183
873
2.46
22.50
2.0
1.9
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
72
203
3.82
22.48
1.7
1.4
g/l
0.0
0.0
0.00
65
186
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
71
199
3.84
22.35
1.7
1.4
g/l
0.0
0.0
0.00
65
185
(3004588) Protein electrophoresis panel - Serum or Plasma
126
503
2.81
22.23
2.5
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
87
282
3.36
22.01
1.7
1.4
g/l
9.8
10.6
1.04
74
235
(3000494) Fungus identified in Specimen by Culture
139
593
2.66
21.51
1.6
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
188
926
2.38
21.41
3.9
2.0
%
1.8
1.8
0.30
165
802
(3021440) Promyelocytes/100 leukocytes in Blood
106
395
2.97
21.18
6.7
3.3
%
0.1
0.1
0.72
41
93
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
644
5203
2.85
21.15
7.9
7.1
mmol/mol
41.3
41.9
0.86
584
4720
(3014576) Chloride [Moles/volume] in Serum or Plasma
174
833
2.42
21.09
7.6
6.0
mmol/l
104.6
104.5
0.06
169
809
(3007853) Bacteria identified in Skin by Aerobe culture
152
684
2.54
21.05
2.0
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
134
570
2.65
20.82
7.7
6.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
94
331
3.11
20.72
1.7
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
50
114
4.63
20.64
3.1
1.6
u/ml
1261.9
76.2
0.52
42
88
(3017181) Myelocytes/100 leukocytes in Blood
108
414
2.88
20.47
6.7
3.2
%
0.8
0.8
0.04
42
101
(3013707) Erythrocyte sedimentation rate by Westergren method
544
4104
2.23
20.39
5.8
4.1
mm/h
15.5
14.6
0.64
502
3718
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
655
5368
2.94
20.34
5.9
5.3
mmol/l
6.2
6.2
0.57
562
4750
(3005719) IgG [Mass/volume] in Serum or Plasma
94
335
3.07
20.28
4.3
1.8
g/l
10.1
11.3
1.16
84
298
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
355
2292
2.06
20.16
2.5
2.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
52
131
4.19
18.91
2.0
2.0
g/l
3.8
3.5
0.43
52
122
(3025159) Blasts/100 leukocytes in Blood
98
373
2.88
18.77
6.9
3.4
%
0.4
0.0
0.52
34
81
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
98
373
2.88
18.77
1.9
1.6
g/l
1.3
1.5
1.04
83
315
(46235355) HIV 1 and 2 tests - Meaningful Use set
102
398
2.81
18.65
1.8
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
17
12
14.48
18.53
1.2
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
88
319
3.00
18.39
1.8
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
96
366
2.87
18.31
6.1
3.3
%
0.4
0.5
0.19
29
75
(3014111) Lactate [Moles/volume] in Serum or Plasma
131
588
2.49
18.06
6.3
5.8
mmol/l
1.3
1.5
1.98
123
563
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
635
5221
2.54
17.79
5.5
4.9
mmol/l
4.1
4.2
1.93
562
4699
(3002032) Base excess in Venous blood by calculation
149
714
2.36
17.76
4.7
3.2
mmol/l
1.5
2.0
0.96
121
571
(3026250) Tacrolimus [Mass/volume] in Blood
22
6
37.72
17.69
21.5
29.5
ug/l
5.9
8.0
—
16
6
(3021447) Carbon dioxide [Partial pressure] in Venous blood
149
718
2.35
17.52
4.7
3.2
kpa
5.7
5.8
0.56
143
693
(3021960) Folate [Moles/volume] in Serum or Plasma
290
1811
1.99
17.40
1.7
1.6
nmol/l
20.7
19.3
0.73
243
1513
(3034860) Kappa light chains.free [Mass/volume] in Serum
71
235
3.24
17.30
3.5
1.4
mg/l
72.4
55.1
0.32
55
189
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
71
235
3.24
17.30
3.5
1.4
mg/l
36.6
37.6
0.07
55
191
(3035350) Ketones [Presence] in Urine by Test strip
398
2779
1.94
17.07
4.5
3.9
estimate
0.0
0.0
0.00
82
473
(3015736) pH of Urine
332
2184
1.94
17.01
3.8
3.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
397
2776
1.93
16.89
6.4
5.2
estimate
0.0
0.0
0.00
85
466
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
626
5161
2.39
16.61
5.4
4.9
mmol/l
1.4
1.4
0.35
544
4609
(3009261) Glucose [Presence] in Urine by Test strip
401
2824
1.92
16.59
4.6
3.9
estimate
0.0
0.0
0.00
85
460
(3021879) Hepatitis B virus core Ab [Presence] in Serum
60
186
3.42
16.22
1.5
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
610
4992
2.27
16.18
4.9
4.4
mmol/l
1.2
1.2
0.42
524
4401
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
117
527
2.45
15.90
5.9
3.7
ng/l
131.9
99.4
1.07
98
446
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
38
6.77
15.83
1.8
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
510
3937
1.95
15.46
3.8
3.4
pmol/l
14.9
15.2
1.41
445
3450
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
32
64
5.18
15.38
1.7
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
433
3176
1.88
15.29
6.0
4.2
ug/l
2.2
2.3
0.29
361
2818
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
71
255
2.97
15.03
2.9
2.8
u/ml
0.4
0.4
0.08
41
155
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
351
2424
1.85
14.88
3.6
3.3
ng/l
2518.7
1921.9
1.28
318
2125
(3022145) Colonoscopy Study observation
106
471
2.46
14.80
1.3
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
125
603
2.29
14.48
3.4
2.7
kpa
4.7
4.4
0.69
117
577
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
35
80
4.54
14.40
1.8
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
137
694
2.20
14.08
3.7
2.2
e9/l
68.2
66.2
0.28
92
546
(3003338) MCHC [Mass/volume]
538
4290
1.93
14.02
37.9
22.2
g/l
329.2
331.6
6.71
533
4245
(3026008) Bacteria identified in Urine by Culture
303
2027
1.84
13.99
3.7
3.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
19
9.13
13.82
1.9
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
40
106
3.93
13.59
1.4
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
103
469
2.39
13.59
2.3
1.8
g/l
0.2
0.2
0.74
94
419
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
37
94
4.09
13.31
2.1
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
108
3.86
13.25
1.7
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
104
481
2.35
13.23
2.0
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
244
1547
1.86
13.23
3.8
2.5
u/l
42.8
36.8
0.31
230
1468
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
123
3.65
13.12
1.5
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
31
70
4.58
12.95
7.5
2.8
%
0.4
2.1
1.23
24
49
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
88
4.13
12.77
1.7
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
168
956
1.98
12.54
7.8
3.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
44
132
3.48
12.51
1.9
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
44
132
3.48
12.51
1.5
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
126
647
2.14
12.42
4.9
3.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
357
2583
1.74
12.11
4.7
4.1
%
22.1
24.6
2.11
158
1344
(3028026) IgM [Mass/volume] in Serum or Plasma
68
271
2.66
11.84
2.5
1.3
g/l
0.9
1.1
0.47
53
244
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
44
137
3.35
11.82
1.9
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
50
169
3.10
11.75
3.9
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
50
170
3.08
11.64
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
50
170
3.08
11.64
1.4
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
50
170
3.08
11.64
2.0
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
102
494
2.24
11.60
6.7
2.6
mmol/l
1.2
1.2
0.19
91
414
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
187
1131
1.87
11.53
1.7
1.6
mg/l
1.5
1.5
0.08
154
889
(3024928) Oxygen saturation in Venous blood
48
161
3.12
11.43
2.3
2.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
222
1420
1.81
11.41
4.9
4.3
ng/l
256.8
349.2
0.41
210
1281
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
393
2953
1.71
11.36
3.3
2.9
u/l
67.5
54.4
1.24
354
2626
(40768797) Stomach Pathology biopsy report
129
701
2.02
10.86
1.3
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
32
85
3.89
10.86
7.9
2.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
47
161
3.05
10.80
1.8
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
27
64
4.34
10.63
1.4
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
138
777
1.95
10.48
2.0
1.2
g/l
2.6
3.0
0.75
79
430
(3020682) Albumin/Creatinine [Ratio] in Urine
314
2259
1.68
10.39
5.4
4.0
mg/mmol
13.8
8.6
1.54
211
1502
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
15
21
7.27
10.16
1.4
2.0
%
16.0
16.3
—
6
9
(3009508) Creatinine [Moles/volume] in Urine
297
2115
1.68
10.16
4.2
3.2
mmol/l
6.5
7.4
5.45
247
1755
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
15
9
16.98
9.90
2.2
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
107
562
2.06
9.85
1.3
1.3
titre
409.6
563.6
0.79
25
135
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
65
4.11
9.57
1.2
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
92
464
2.12
9.41
1.7
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
23
53
4.45
9.39
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
294
2123
1.64
9.32
4.2
3.3
mg/l
82.2
228.9
1.45
200
1416
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
32
95
3.48
9.27
1.5
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
29
81
3.69
9.19
1.7
1.5
e6/l
48645.9
106633.6
0.32
14
47
(3012441) Differential panel - Pleural fluid
27
72
3.85
9.13
1.6
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
27
72
3.85
9.13
1.7
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
24
59
4.17
9.04
4.9
3.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
26
68
3.93
9.02
1.7
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
57
239
2.50
8.96
3.3
1.9
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
30
88
3.51
8.85
1.6
1.5
e6/l
1032.1
1796.4
0.76
17
64
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
86
436
2.10
8.67
1.7
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
31
95
3.36
8.57
1.6
1.4
g/l
29.4
26.5
0.62
26
87
(3052851) Hemolysis interference index of Serum or Plasma
47
184
2.66
8.49
4.6
3.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
130
783
1.80
7.88
2.9
3.3
ng/l
298.1
287.9
0.07
120
734
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
249
1787
1.59
7.79
3.2
2.2
u/l
65.5
58.8
0.46
236
1635
(3011397) Hemoglobin [Presence] in Urine by Test strip
207
1421
1.63
7.77
3.7
3.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
30
96
3.21
7.76
1.5
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
21
6.28
7.73
2.1
2.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
53
231
2.39
7.68
3.1
3.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
20
49
4.17
7.58
1.4
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
22
59
3.81
7.40
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
27
84
3.30
7.31
1.6
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
79
3.37
7.30
5.7
3.0
%
53.8
59.8
1.14
26
79
(3003694) ABO and Rh group [Type] in Blood
180
1210
1.64
7.29
1.3
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
227
1616
1.58
7.25
1.8
1.8
nmol/l
1212.3
1156.0
0.28
159
1223
(3022217) INR in Platelet poor plasma by Coagulation assay
170
1129
1.66
7.21
40.7
33.5
inr
1.7
1.6
0.41
22
144
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
38
4.56
7.21
1.2
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
16
6.96
7.16
1.3
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
36
136
2.73
7.00
1.5
1.4
ug/g
283.5
281.4
0.02
22
91
(3024891) Influenza virus A+B Ag [Presence] in Specimen
35
131
2.75
6.92
1.3
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
38
151
2.60
6.70
2.8
2.1
%
15.9
16.0
0.03
23
80
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
21
5.79
6.60
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
200
1409
1.58
6.59
1.7
1.6
mmol/l
1.2
1.3
1.28
155
1149
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
16
38
4.28
6.31
1.2
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
16
38
4.28
6.31
1.2
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
30
4.74
6.23
1.1
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
30
4.74
6.23
4.0
3.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
24
77
3.19
6.21
5.1
2.7
e9/l
4.2
4.8
0.62
24
77
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
19
5.86
6.12
2.4
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
44
196
2.32
6.11
4.2
3.1
mmol/l
23.4
24.6
1.08
39
169
(3010421) pH of Blood
41
177
2.39
6.11
5.6
3.8
ph
7.4
7.4
0.09
34
144
(3013727) Leukocytes other/100 leukocytes in Blood
10
8
12.65
6.09
11.3
2.0
%
44.5
65.7
—
10
8
(44790048)
22
68
3.30
6.04
1.9
1.3
—
—
—
0
0
(44790049)
22
68
3.30
6.04
1.9
1.3
—
—
—
0
0
(44806118)
22
68
3.30
6.04
1.9
1.3
—
—
—
0
0
(44790047)
22
68
3.30
6.04
1.9
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
31
4.58
6.00
1.1
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
39
166
2.42
5.99
2.6
2.0
g/l
123.8
130.7
0.86
29
123
(40761536) Microorganisms panel - Urine sediment
78
437
1.88
5.93
7.3
3.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
35
144
2.50
5.78
3.0
2.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
48
228
2.18
5.74
1.4
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
14
33
4.31
5.58
1.4
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
35
147
2.45
5.55
5.9
3.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
21
5.30
5.54
2.2
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
77
440
1.84
5.51
3.9
2.5
ml/min/173m2
50.2
55.2
0.58
47
191
(3017446) Testosterone [Moles/volume] in Serum or Plasma
59
309
1.99
5.47
2.1
2.2
nmol/l
12.0
14.7
1.39
51
260
(3012501) Base excess in Blood by calculation
35
148
2.43
5.47
5.4
4.0
mmol/l
2.0
3.0
1.55
24
94
(3003396) Base excess in Arterial blood by calculation
128
845
1.62
5.46
6.6
5.8
mmol/l
0.0
1.3
2.67
107
640
(3048929) Epstein Barr virus Ab [Presence] in Serum
23
78
3.01
5.46
1.2
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
131
870
1.61
5.45
1.2
1.2
u/ml
2.0
1.9
0.05
23
221
(3005322) IgE [Units/volume] in Serum or Plasma
48
233
2.13
5.45
1.3
1.2
u/ml
153.7
239.8
0.69
43
213
(3041096) Erythrocytes [Presence] in Urine by Automated
192
1392
1.51
5.43
5.3
3.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
268
2080
1.45
5.38
2.5
2.2
u/l
215.5
285.4
0.57
251
1926
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
335
2713
1.43
5.32
4.8
4.5
ng/l
47.1
63.7
0.67
273
2157
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
65
356
1.91
5.30
2.3
2.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
144
2.43
5.30
1.7
1.5
iu/ml
0.3
0.2
0.02
12
39
(3000093) Morphology [Interpretation] in Blood Narrative
20
64
3.18
5.22
1.0
1.2
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
0
+∞
5.21
1.6
0.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
6
13.46
5.09
1.4
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
19
5.32
5.05
10.6
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
9
9
10.10
5.03
1.3
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
56
299
1.94
4.94
1.9
1.7
ug/l
1.3
2.0
0.47
49
257
(3036782) Glucose [Moles/volume] in Pleural fluid
19
62
3.12
4.82
1.4
1.3
mmol/l
6.0
7.5
0.74
19
57
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
68
3.00
4.74
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
73
433
1.76
4.63
2.4
1.9
ug/g
231.4
194.1
0.15
62
326
(3019230) Fractional oxyhemoglobin in Venous blood
29
123
2.41
4.54
1.8
2.0
%
64.6
60.9
0.36
29
123
(1761868) Lipid panel - Serum or Plasma
180
1331
1.47
4.53
3.9
3.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
60
3.05
4.42
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
13
6.99
4.17
1.1
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
32
3.80
4.10
3.8
3.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
18
63
2.90
4.08
1.2
1.0
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
7
7
10.08
4.01
1.6
1.1
umol/l
1.8
1.6
—
7
7
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
69
423
1.70
3.92
5.0
3.7
mmol/l
1.7
1.9
0.11
42
309
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
59
2.93
3.92
10.8
2.9
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
59
346
1.77
3.92
5.1
2.7
e6/l
0.4
0.3
0.04
59
341
(3009343) pH of Capillary blood
71
440
1.68
3.88
5.3
3.7
ph
7.4
7.4
0.06
18
58
(3007566) Smooth muscle Ab [Titer] in Serum
27
120
2.30
3.85
1.1
1.0
—
68.8
—
0
8
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
60
2.88
3.81
1.2
1.0
u/ml
245.2
327.2
0.74
11
28
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
105
721
1.53
3.76
1.2
1.3
iu/ml
53.3
41.9
0.29
23
220
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
19
72
2.68
3.75
1.1
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
16
5.68
3.66
2.2
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
30
3.71
3.65
1.1
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
20
80
2.54
3.57
3.1
2.9
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
71
452
1.63
3.51
5.3
3.7
kpa
5.0
5.2
0.79
62
416
(3037121) Protein [Mass/volume] in Urine
40
216
1.90
3.47
2.9
2.4
g/l
0.4
0.3
0.66
20
73
(3022806) Fractional oxyhemoglobin in Capillary blood
21
88
2.43
3.42
1.6
1.5
%
85.6
89.6
0.51
21
88
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
10
27
3.74
3.36
1.1
1.1
u/l
159.2
105.2
—
10
22
(3017354) Segmented neutrophils/100 leukocytes in Blood
15
54
2.81
3.27
5.9
2.6
%
52.4
57.0
—
8
35
(3004119) Hemoglobin [Mass/volume] in Venous blood
74
485
1.58
3.26
3.9
2.8
g/l
118.3
128.7
3.50
74
471
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
20
84
2.42
3.25
4.5
3.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
16
60
2.70
3.24
1.0
1.0
g/l
1.5
1.6
0.24
16
51
(4034850)
7
218
0.31
3.24
11.0
12.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
17
67
2.57
3.14
1.8
1.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
13
45
2.92
3.03
1.5
1.2
u/l
14.3
15.6
0.26
13
40
(3042733) HLA Ab [Presence] in Serum
5
5
10.06
2.98
5.2
7.4
—
—
—
0
0
(3013512) EKG study
235
1934
1.32
2.95
5.9
4.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
13
5.42
2.87
1.1
1.2
%
81.3
76.2
—
7
13
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
165
1.92
2.85
1.1
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
10
6.04
2.70
1.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
193
1563
1.32
2.69
5.4
4.2
estimate
0.0
0.0
0.00
75
443
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
163
1.88
2.61
1.1
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
163
1.88
2.61
1.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
15
4.70
2.60
1.0
1.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
11
5.49
2.54
3.2
1.1
nmol/l
461.7
76.5
—
6
11
(40768446) Kidney Pathology biopsy report
6
11
5.49
2.54
1.8
1.6
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
16
4.41
2.48
1.6
1.1
umol/l
26.1
27.5
—
7
16
(3045424) Erythrocytes [Presence] in Urine
15
63
2.41
2.47
1.5
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
30
167
1.83
2.44
1.1
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
12
5.03
2.40
1.0
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
12
5.03
2.40
4.0
2.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
27
3.36
2.40
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
33
191
1.76
2.37
1.0
1.2
iu/ml
201.4
90.6
0.41
11
71
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
8
6.28
2.37
1.2
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
40
246
1.66
2.33
1.2
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
55
366
1.54
2.33
9.7
8.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
50
326
1.57
2.31
1.1
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
6
13
4.64
2.27
1.7
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
23
3.50
2.27
1.4
1.1
—
—
—
0
0
(3000492) Spirometry study
53
355
1.53
2.19
2.2
1.5
—
—
—
0
0
(4281824)
7
19
3.71
2.15
1.3
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
14
4.31
2.15
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
249
2143
1.24
2.07
5.5
4.2
—
—
—
0
0
(3035880) pH of Pleural fluid
10
38
2.65
2.01
1.3
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
21
3.35
1.97
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
188
1.68
1.94
1.2
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
33
2.75
1.93
1.4
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
10
39
2.59
1.92
1.2
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
44
292
1.54
1.92
2.6
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
41
269
1.55
1.88
2.2
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
19
100
1.92
1.87
3.5
2.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
18
93
1.96
1.86
1.3
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
122
1.83
1.86
1.8
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
90
689
1.35
1.84
1.1
1.3
u/ml
30.8
14.1
0.59
27
226
(3023410) Appearance of Cerebral spinal fluid
10
40
2.52
1.84
1.1
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
15
73
2.08
1.81
4.1
2.4
ml
981.9
586.0
—
10
45
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
23
3.06
1.80
5.4
2.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
29
2.78
1.79
1.8
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
96
747
1.33
1.77
2.4
2.7
ug/l
6.3
7.3
0.27
85
643
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
18
3.35
1.75
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
52
366
1.45
1.74
1.3
1.6
%
1.7
1.8
0.04
40
292
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
61
2.15
1.72
1.1
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
62
2.12
1.66
1.1
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
14
3.59
1.62
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
50
2.22
1.57
1.4
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
44
2.29
1.53
2.8
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
44
2.29
1.53
2.8
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
44
2.29
1.53
2.8
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
15
3.35
1.52
1.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
27
2.61
1.51
1.1
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
27
2.61
1.51
1.7
1.5
g/l
0.9
0.9
—
7
27
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
21
2.87
1.51
1.2
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
21
2.87
1.51
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
66
499
1.35
1.50
1.6
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
69
528
1.34
1.45
3.1
4.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
29
2.43
1.39
1.3
1.5
pmol/l
228.4
78.8
—
7
29
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
23
2.62
1.37
1.0
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
42
2.16
1.34
2.4
1.3
ug/l
15.0
16.5
—
9
42
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
68
1.93
1.34
2.8
2.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
18
2.79
1.28
3.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
17
99
1.73
1.28
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
36
2.24
1.24
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
37
2.17
1.21
2.0
1.9
—
—
—
0
0
(4062490)
8
38
2.12
1.18
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
33
232
1.44
1.17
2.9
2.1
—
—
—
0
0
(4010399)
54
416
1.32
1.13
1.5
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
3.2
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
3.2
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
3.2
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
3.2
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
41
1.96
1.09
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
47
1.93
1.02
1.4
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
155
1.50
1.02
1.5
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
48
1.89
1.00
1.8
3.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
35
2.01
1.00
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
49
1.85
0.99
3.7
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
18
116
1.57
0.97
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
11
62
1.79
0.94
1.1
1.2
mu/l
37.0
53.3
—
6
55
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
52
1.74
0.92
3.7
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
22
152
1.46
0.89
1.6
1.5
e6/l
11021.8
21063.3
0.91
14
107
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
87
1.62
0.88
1.1
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
35
264
1.34
0.87
1.1
1.3
—
66.0
—
0
12
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
170
1.43
0.86
1.3
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
45
1.79
0.84
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
41
321
1.29
0.81
6.7
3.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
18
123
1.47
0.78
1.3
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
91
1.55
0.75
1.2
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
9
54
1.67
0.74
1.1
1.2
mmol/l
40.8
35.7
—
9
49
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
21
150
1.41
0.74
1.4
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
55
1.64
0.73
1.4
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
117
1.46
0.72
1.7
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
40
1.76
0.71
1.1
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
49
401
1.24
0.70
5.8
2.8
mmol/l
24.6
25.0
0.33
49
387
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
7
41
1.71
0.70
1.1
1.2
—
1.4
—
0
14
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
13
85
1.54
0.69
1.2
1.2
—
48.2
—
0
6
(3008037) Lactate [Moles/volume] in Venous blood
25
187
1.35
0.69
5.4
2.9
mmol/l
1.4
1.8
1.77
25
182
(3017704) Immunofixation for Urine
7
42
1.67
0.68
1.0
1.3
—
—
—
0
0
(3020891) Body temperature
38
304
1.26
0.66
4.6
4.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
44
1.60
0.65
1.6
1.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
29
1.73
0.64
1.6
2.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
173
1586
1.12
0.62
1.7
1.8
pmol/l
484.8
12189862.1
1.06
129
1288
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
30
1.67
0.61
1.4
1.2
mmol/l
1.8
2.1
—
5
30
(3021387) Prolactin [Units/volume] in Serum or Plasma
8
51
1.57
0.60
2.3
2.1
mu/l
427.4
242.3
—
8
44
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
51
1.57
0.60
1.1
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
67
578
1.18
0.58
4.1
3.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
38
310
1.24
0.58
3.6
3.9
%
0.9
0.9
0.04
38
299
(3008898) HLA-B27 [Presence]
11
74
1.49
0.53
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
67
766
0.86
0.53
5.4
5.1
%
33.9
33.6
0.08
42
497
(3004616) Nuclear Ab [Presence] in Serum
9
62
1.46
0.53
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
100
1.41
0.52
1.4
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
17
126
1.36
0.52
1.2
1.4
mmol/l
56.6
64.4
0.41
17
101
(4306422)
6
40
1.50
0.51
1.2
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
40
334
1.21
0.51
3.0
3.0
e9/l
3.8
4.2
0.36
21
218
(3013139) Helicobacter pylori Ag [Presence] in Stool
35
289
1.22
0.50
1.1
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
45
1.56
0.49
1.1
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
14
103
1.37
0.45
1.4
1.8
nmol/l
60.6
49.2
0.63
14
94
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
44
376
1.18
0.45
6.5
3.5
%
45.4
47.9
0.26
44
369
(3001019) Free T4 and TSH panel - Serum or Plasma
7
50
1.40
0.45
1.7
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
76
848
0.88
0.44
10.3
8.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
22
175
1.27
0.43
6.0
3.0
mmol/l
7.3
7.9
0.51
22
169
(4094501)
9
131
0.68
0.43
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
32
1.57
0.42
1.0
1.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
33
277
1.20
0.42
3.8
3.8
mmol/l
1.8
1.5
0.40
33
272
(3019150) Specific gravity of Urine by Refractometry
125
1351
0.91
0.41
4.4
4.4
kg/l
1.0
1.0
0.30
20
228
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
15
0.00
0.41
0.0
1.1
—
17.4
—
0
7
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
79
1.40
0.41
1.5
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
60
1.34
0.40
1.0
1.2
u/ml
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
60
1.34
0.40
2.3
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
60
1.34
0.40
2.3
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
60
1.34
0.40
1.6
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
61
1.31
0.39
2.3
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
61
1.31
0.39
2.3
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
70
1.29
0.36
1.6
2.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
26
217
1.21
0.36
2.5
3.5
nmol/l
0.7
0.8
1.51
21
174
(3044941) Cell count panel - Synovial fluid
13
99
1.32
0.35
1.5
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
136
1.26
0.34
1.9
1.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
100
1.31
0.33
1.1
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
110
1.28
0.32
1.6
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
62
1.29
0.28
2.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
62
1.29
0.28
2.3
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
26
224
1.17
0.27
5.7
4.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
65
1.23
0.27
1.6
1.2
nmol/l
0.7
0.6
—
8
60
(3019225) pH of Specimen
68
628
1.09
0.25
7.1
3.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
87
1.27
0.24
1.5
1.3
—
—
—
0
0
(3039000) Anion gap in Blood
14
169
0.83
0.24
3.9
5.0
mmol/l
11.3
11.1
0.07
14
159
(3018572) Chloride [Moles/volume] in Blood
14
169
0.83
0.24
3.9
5.1
mmol/l
104.6
105.3
0.18
14
159
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
39
1.28
0.23
1.8
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
40
1.25
0.22
1.8
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
10.6
—
0.7
—
0
10
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
117
1.20
0.20
1.7
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
48
1.25
0.20
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
42
385
1.10
0.19
6.6
3.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
146
1.17
0.19
4.3
2.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
72
1.11
0.16
2.1
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
96
0.83
0.14
1.6
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
211
1.09
0.11
5.4
2.3
ug/min
110.0
70.7
0.39
15
127
(3033705) Calcium.ionized [Moles/volume] in Venous blood
12
106
1.13
0.10
5.3
2.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
47
450
1.05
0.08
3.9
3.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
64
1.09
0.08
1.0
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
65
1.08
0.08
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
225
1.07
0.07
1.3
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
105
0.86
0.06
1.0
1.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
12
110
1.09
0.05
5.3
2.3
mmol/l
107.0
105.3
0.50
12
110
(3041354) Potassium [Moles/volume] in Venous blood
12
110
1.09
0.05
5.3
2.3
mmol/l
4.1
4.1
0.08
12
110
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
41
397
1.03
0.04
1.3
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
97
1.03
0.00
1.3
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
97
1.03
0.00
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.2
—
84.7
—
0
6
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
56
0.89
0.00
1.0
1.2
nmol/l
0.6
1.5
—
5
47
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
1.8
—
0
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
80
1.00
0.00
1.1
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
3.0
—
13.8
—
0
6
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
12.2
—
0
5
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
60
1.00
0.00
1.8
1.2
nmol/l
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
54
0.93
0.00
1.0
1.4
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
96
0.94
0.00
1.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(4146454)
7
79
0.88
0.00
2.9
2.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_SCALPNECK_EXALLC – Carcinoma in situ of skin of scalp and neck
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).